AVAH earnings analysis
What we found in AVAH's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied excerpt does not contain the current quarter’s income statement, balance sheet, cash-flow statement, segment disclosures, or MD&A, so revenue, margins, EPS, free cash flow, working-capital trends, and segment performance cannot be determined from the available filing text. The principal quantified balance-sheet and market-risk disclosure is $1.5 billion of variable-rate debt, with $1.4 billion covered by interest-rate caps and approximately $83.4 million unhedged. Management reported effective disclosure controls as of July 4, 2026, and stated that there were no material changes to the risk factors from the January 3, 2026 10-K.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Substantial Debt Hedged Against Rates
- Variable-rate debt outstanding was $1.5 billion as of July 4, 2026. Interest-rate cap agreements covered an aggregate notional amount of $1.4 billion, including $880.0 million at a 2.96% cap rate and $520.0 million at a 4.00% cap rate.
- Controls Reported Effective
- Management reported that disclosure controls and procedures were effective as of July 4, 2026. It also reported no changes in internal control over financial reporting during the three-month period ended July 4, 2026 that materially impacted, or were reasonably likely to materially impact, those controls.
- Limited Unhedged Rate Exposure
- The company had approximately $83.4 million of unhedged variable-rate debt as of July 4, 2026. The filing states that a 100-basis-point rate increase would increase annual interest expense by approximately $2.7 million.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Interest-Rate Exposure
- The company had $1.5 billion of outstanding variable-rate debt as of July 4, 2026. Although rate caps covered $1.4 billion of notional exposure, a 100-basis-point increase applied to approximately $83.4 million of unhedged variable-rate debt would increase annual interest expense by approximately $2.7 million.
- Hedge Expiration Risk
- The 2027 and 2029 interest-rate cap agreements expire on February 28, 2027 and December 31, 2029, respectively. The filing therefore identifies a defined expiration point for part of the company’s rate protection.
- Inherent Control Limitations
- The company states that controls provide only reasonable, not absolute, assurance and may be circumvented through individual acts, collusion, or management override. It also states that future evaluations are subject to risks and that controls may become inadequate as conditions change.
What they said about what is next.
The supplied 10-Q excerpt does not include MD&A, financial statements, or quantitative outlook language. The prior 8-K reported 2026 revenue guidance of $2.63 billion-$2.65 billion, but no current-quarter guidance update is provided here.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 14, 2026
- Aveanna Healthcare reported strong Q1 2026 results with revenue of $647.9 million, a 15.9% increase from $559.2 million in Q1 2025, surpassing expectations. Adjusted EPS reached $0.19, well above the consensus estimate…
- 10-K · March 19, 2026
- Aveanna reports strong 2025 operating performance with revenue of $2,433,000,000 (sum of 2025 quarters), gross margin expansion and an EPS turnaround to $1.05 for the year driven by Q4 2025 revenue of $662,480,000 and…
- 10-Q · November 6, 2025
- Aveanna reported third-quarter revenue of $621.9M (up $112.9M or 22.2% YoY) driven in part by the June 2, 2025 Thrive acquisition. Gross margin was 32.6% and operating margin 8.6%, producing operating income of $53.6M…
- 10-Q · May 8, 2025
- Aveanna reported Q1 revenue of $559.2M, up $68.6M (≈14.0%) versus Q1 2024, with operating income rising to $51.8M (9.3% margin) from $22.9M. The company generated net income of $5.2M (basic EPS $0.03) versus a loss of…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing AVAH makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever